Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06323031Recruiting

Spontaneous Eye Blinking in Disorders of Consciousness

Role: collaborator

NCT04401319Not ApplicableUnknown

rTMS and EEG in DOC Patients

Role: collaborator

NCT02639481Phase 3Completed

Erigo®Pro Coma Outcome Study - Study on the Effectiveness of a Robotic Tilt Table Device for Recovery of Consciousness

Role: collaborator

NCT02231060Completed

Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest

Role: collaborator

All 4 trials loaded